#141: Dispensary by IYHP (17/11)

1. India IVF raised $1.25M to expand its fertility services.

2. TA Associates to acquire majority stake in Vee Healthtek for $250M

1. Cardinal Health expands gastroenterology, diabetes businesses with two deals worth $3.9 bln

2. Metsera raised $215M in Series B financing to advance its novel therapeutics pipeline.

3. Alentis Therapeutics secured $181.4M in Series D funding to accelerate its fibrosis and oncology programs.

1. Trebio raised $84M in Series B financing to expand its immunotherapy research.

2. Zap Surgical Systems raised $78M in Series E funding to develop and commercialize its radiosurgery technology.

3. Beta Bionics closed $60M in Series E financing to further its work on automated insulin delivery systems.

4. Impress received $40M in growth financing from Trinity Capital.

5. Stepful raised $31.5M in Series B funding to scale its healthcare training platform.

6. Plantible Foods raised $30M in Series B funding to expand its plant-based protein production.

7. Homethrive raised $20M in funding to grow its family caregiver support services.

8. Zucara Therapeutics secured $20M in Series B financing to develop diabetes treatments.

9. Mediaire raised €12M in funding to advance its AI-powered radiology software.

10. Impilo raised $11.5M in Series A funding to expand its digital health platform.

1. Fort Health raised $5.5M to expand its mental health services for children.

2. MyBiometry raised $5M in seed funding for its digital health platform.

3. Biolux Technology raised $4.5M to advance its orthodontic devices.

4. Mithrl raised $4M in seed funding to develop its AI-driven drug discovery platform.

5. Sunthetics raised $4M in seed funding to create sustainable chemical manufacturing solutions.

6. Paloma Health raised $2M in pre-seed funding to develop its digital thyroid care platform.

7. Novel Microdevices received ~$2.7M in follow-on funding from the NIH RADx initiative.

1. Genesis Therapeutics received an equity investment from NVIDIA to advance its AI-driven drug discovery.

2. Divi received a minority investment from Norwest to grow its platform.

3. General Prognostics received an investment from NEC X to enhance its AI-driven healthcare monitoring tools.

4. AlloVir and Kalaris Therapeutics announced a merger to create a stronger platform for infectious disease treatments.

5. OneSkin closed a Series A funding round to accelerate the development of its anti-aging skincare technology.

6. EpiBone completed a funding round to advance its tissue-engineered bone solutions.

• Chinese Pharma Major Shanghai Pharma Seeking API Imports from India

• India’s Rs 500 crore MedTech scheme to boost domestic manufacturing and export of medical devices

• Dengue surge exposes Civil Hospital’s healthcare system

• Parasitic infections from pork consumption in northeast India: A growing concern for Public Health

• India needs to expand local vaccine manufacturing, research: GTRI report

• Telangana secures over Rs 36,000 crore in life sciences investments, genome valley leads the way

• RFK Jr vow to purge FDA sets up collision with Big Pharma

• A New Digital Health Platform for Africa

• China to pilot standards for virtual primary care

• Exclusive: Pfizer explores sale of hospital drugs unit, sources say

• Many long COVID patients adjust to slim recovery odds as world moves on

• Rising Resistance Threatens a Key Malaria Drug

• HemaChrome collaborates with Global Health Labs to enhance its mobile health technology to test blood hemoglobin

As always, we're here to keep you informed and up to speed with the latest in healthcare. With close to 1,500 subscribers already in the know, you're in great company. If you haven't yet, feel free to hit subscribe and never miss an update.

That’s it, until next week.

Rahul and Aditya